About Alvogen
Alvogen is a company based in Montville (United States) founded in 2009 was acquired by Lotus in September 2025.. Alvogen has raised $155.92 million across 2 funding rounds from investors including Morgan Stanley, Lotus and IMM Investment. Alvogen has completed 7 acquisitions, including County Line Pharma, County Line Pharmaceuticals and Dolphin. Alvogen offers products and services including Generic Drugs and Injectables.
- Headquarter Montville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alvogen, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$155.92 M (USD)
in 2 rounds
-
Latest Funding Round
$100 M (USD), Series D
Jun 30, 2021
-
Investors
Morgan Stanley
& 4 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
County Line Pharma
& 6 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alvogen
Alvogen offers a comprehensive portfolio of products and services, including Generic Drugs and Injectables. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Generic drugs are developed and marketed by Alvogen as part of its core portfolio to provide accessible alternatives to branded medications
Injectables are manufactured and distributed by Alvogen, focusing on complex, high-value products that support various medical treatments
Unlock access to complete
Funding Insights of Alvogen
Alvogen has successfully raised a total of $155.92M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $100 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $100.0M
-
First Round
First Round
(01 Jun 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series D - Alvogen | Valuation | Morgan Stanley |
|
| Jun, 2012 | Amount | Series C - Alvogen | Valuation | IMM Private Equity |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alvogen
Alvogen has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Morgan Stanley, Lotus and IMM Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
IMM Investment is recognized as a leading multi-asset alternative investment firm in Asia.
|
Founded Year | Domain | Location | |
|
Private equity investment firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Wealth management, investment advisory, and financial services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alvogen
Alvogen has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include County Line Pharma, County Line Pharmaceuticals and Dolphin. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online drug information is provided via GRALISE's digital platform.
|
2010 | ||||
|
Generic solid and liquid dosage forms are manufactured and marketed.
|
2007 | ||||
|
Generic pharmaceutical products are manufactured across therapeutic categories.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Alvogen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alvogen Comparisons
Competitors of Alvogen
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alvogen
Frequently Asked Questions about Alvogen
When was Alvogen founded?
Alvogen was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Alvogen located?
Alvogen is headquartered in Montville, United States. It is registered at Montville, New Jersey, United States.
Who is the current CEO of Alvogen?
Lisa Graver is the current CEO of Alvogen.
Is Alvogen a funded company?
Alvogen is a funded company, having raised a total of $155.92M across 2 funding rounds to date. The company's 1st funding round was a Series C of $55.92M, raised on Jun 01, 2012.
What does Alvogen do?
Alvogen was founded in 2009 and is headquartered in Montville, United States. Operations in the pharmaceutical sector involve developing, in-licensing, manufacturing, and marketing a range of products, including generic drugs, branded items, injectables, and complex medications such as inhalation therapies and 505(b)(2) formulations. A research and development program supports the pipeline, while ethical practices and transparency guide interactions with healthcare providers.
What products or services does Alvogen offer?
Alvogen offers Generic Drugs and Injectables.
How many acquisitions has Alvogen made?
Alvogen has made 7 acquisitions, including County Line Pharma, County Line Pharmaceuticals, and Dolphin.
Who are Alvogen's investors?
Alvogen has 5 investors. Key investors include Morgan Stanley, Lotus, IMM Investment, Aztiq, and Pamplona Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.